San Diego-based iBio, an AI-driven innovator of precision antibody therapies, has announced a licensing agreement with ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...

US clinical-stage biotech Halda Therapeutics today announced that Dr Eyal Attar has joined the company as chief medical ...

A clinical-stage biotech company developing bifunctional small-molecule therapeutics designed to eliminate disease-driving ...

Harvard University has filed a lawsuit against the US government after more than $2 billion in federal research funding was ...

A clinical-stage biotech company developing first-in-class targeted and immune-mediated therapeutics to fight cancer.

Japan’s Ono Pharmaceutical and privately-held US firm Jorna Therapeutics are ready to go in a research collaboration ...

Galapagos (Euronext: GLPG) has appointed Henry Gosebruch as chief executive of its upcoming oncology spin-off, marking a ...

Russian public procurements of drugs based on the active ingredient semaglutide, which is an original drug from Denmark’s ...

Physician attitudes toward patient choice between the use of biologics and biosimilars vary widely across global markets, ...

Zymeworks (Nasdaq: ZYME), a clinical-stage biotech developing antibody-based therapies for cancer and immune diseases, has ...

US biotech major Gilead Sciences (Nasdaq: GILD) today announced positive top-line results from the Phase III ...